Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for Non-Melanoma Skin Cancer Patients Treated with Sensus Healthcare's Superficial Radiation Therapy

Stock Information for Sensus Healthcare Inc.

Loading

Please wait while we load your information from QuoteMedia.